Delivery Order SPE2DR25D2014-SPE2DR26FZ87W
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,785.37 to AmerisourceBergen Drug Corp for the supply of Digifab 40 mg vials. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a non-competitive award made under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $26,898.55 to AmerisourceBergen Drug Corp for the supply of Digifab 40 mg vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,738,224 units of the pharmaceutical product DIGIFAB 40 MG VIALS. The contract has a potential value of $37,013.12 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,064.55 to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of DIGIFAB 40 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,708.88 firm-fixed-price delivery order is for 4560539206 DIGIFAB 40 MG VIALS, with an ultimate completion date of April 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,044.15 firm fixed-price delivery order is for the supply of DIGIFAB 40 MG VIALS, a medical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIGIFAB 40 MG VIALS medical supplies. The award, with a ceiling value of $45,245.21, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $94,512.90 to AmerisourceBergen Drug Corp on October 27, 2025, with an ultimate completion date of October 28, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $199,984.81 to AmerisourceBergen Drug Corp on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order, issued under a non-competitive, non-set-aside procurement, represents a child contract drawn from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work...
- The Defense Logistics Agency's Medical Supply Chain awarded a $571,441.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion targeted for October 21, 2025. This non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order represents a discrete pharmaceutical or medical supply...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ87WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,707.24 to AmerisourceBergen Drug Corp for 40 mg Digifab vials, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract vehicle enables the company to deliver specialty medications, brand-name and generic drugs, vaccines, and other pharmaceutical products across multiple therapeutic domains to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/3/25 |